Objective: We investigated the associations of inflammatory blood cell activation with vascular parameters in patients with type 2 diabetes to elucidate the possible mechanisms of accelerated atherosclerosis observed in subjects with the Leucine 7 to Proline 7 polymorphism (Leu7Pro) in the neuropeptide Y (NPY). Methods: Our study included 31 Caucasian patients with type 2 diabetes; 12 of them had the Leu7Pro7 (heterozygous), and 19 had the Leu7Leu7 (wild type) genotype. Vascular parameters were determined by ultrasound methods. Leukocyte analyses were performed from blood samples using flow cytometry. NPY concentrations were determined in plasma. Results: The amount of platelet-granulocyte complexes was positively correlated with NPY concentration (p=0.008) and carotid intima-media thickness (p=0.035) in the Leu7Pro7 group. Interferon gamma (IFN-γ) expression in monocytes correlated negatively with brachial artery flow-mediated dilatation also in the Leu7Pro7 group (p=0.037). The expression of tissue factor on monocytes correlated negatively with brachial artery diameter in the Leu7Pro7 patients as well (p=0.019).
Introduction
In diabetes mellitus (DM), the risk of vascular disease is greatly increased. 1 DM is characterised by endothelial dysfunction, 2 which is considered to be the first step in atherosclerosis progression. Atherosclerosis is an inflammatory disease, in which endothelial adhesion molecules recruit immune cells to the arterial intima, where macrophages and T cells secrete cytokines, recruiting more inflammatory cells and enhancing lipid-rich foam cell formation. 3 CD4-positive T helper (Th) cells are important regulators of this inflammatory response. They can further be divided into two groups, Th1 and Th2, by the different cytokines they produce. 4 Th1 cells are predominently found in atherosclerotic plaques, where Th2 cells are scarce. 5, 6 Th1 cells are considered proatherogenic, since interferon gamma (IFN-γ) secreted by these cells has been demonstrated to have a variety of proatherogenic effects. 7 The activation status of T cells can be measured using the HLA-DR antibody, since this antigen is up-regulated upon T-cell activation.
A part of the macrophage-1 antigen (Mac-1), CD11b, mediates binding and extravasation of leukocytes. [8] [9] [10] CD11b is abundant on neutrophils and monocytes and upregulated upon their activation. 11 Furthermore, tissue factor (TF) is an essential initiator of the coagulation cascade and is expressed in atherosclerotic lesions. 12 Also, the formation of platelet-leukocyte complexes has been shown to correlate with leukocyte activation in human blood. 13 The Leu7Pro polymorphism in neuropeptide Y (NPY) associates with increased intima-media thickness (IMT) of arteries in patients with type 2 diabetes, indicating accelerated atherosclerosis 14 and increased serum cholesterol levels. 15 In type 1 diabetes and hypertension patients, the Leu7Pro polymorphism has been associated with cardiovascular events. 16, 17 NPY has many immunomodulatory functions: it regulates adhesion and cytokine secretion of T cells, 18, 19 stimulates chemotaxis of monocytes 20 and modulates the functions of macrophages. 21 However, the precise role of NPY in the inflammatory cascade in atherosclerosis is not known.
In this study, we investigated vascular parameters of atherosclerosis using non-invasive ultrasound-based methods and measured several inflammatory parameters in blood cells. The associations of these vascular parameters with the inflammatory cell parameters were studied in subjects with and without the Leu7Pro polymorphism of the NPY gene, in patients with type 2 diabetes, to elucidate possible NPY-and/or genotype-related inflammatory mechanisms in the development of atherosclerosis.
Methods

Study subjects and design
This cross-sectional study was approved by the Ethical Committee of the Hospital District of Southwest Finland and written informed consent was received from each study subject for genotyping and for each study part. The procedures followed were in accordance with the ethical standards of the responsible Committee on human experimentation and with the Declaration of Helsinki 1975, revised Hong Kong 1989. The study subjects were selected from a cohort of 150 Caucasian patients with type 2 diabetes (outpatients of the Turku Health Care Centre), whose diabetes' duration was less than 10 years before recruitment and who had no signs of the development of retinopathy in their latest ophthalmologic retinal images. All subjects were genotyped for the Leu7Pro (NPY1228T>C) polymorphism (rs16139). Exclusion criteria were pathological obesity (body mass index (BMI) >40), psychiatric disease, alcohol or drug abuse and smoking. For 12 patients with the Pro7 allele (Leu7Pro7 genotype) 19 pair-matched (by age, sex, BMI, diabetes duration and haemoglobin A1 C (HbA1c)) control patients without the Pro7 allele (Leu7Leu7 genotype) were selected from the cohort. Five subjects with the Pro7 allele had two control pairs without the Pro7 allele, which was taken into account in the analyses. For lymphocyte sub-class determination, 24 pair-matched subjects were available.
The study subjects attended a careful physical examination performed by a physician (including electrocardiogram, cardiac and pulmonary auscultation, blood pressure measurement, abdominal palpation, weight, length and waist measurements). The medical history was taken and basic laboratory measurements (blood haemoglobin concentration (Hb), leukocyte count, erythrocyte sedimentation rate, total cholesterol, low-density lipoprotein (LDL) and highdensity lipoprotein (HDL) cholesterol concentrations, triglycerides, HbA1 C , fasting plasma glucose, fasting insulin, alanine transferase (alat), creatinine (crea) and C-peptide concentration) were performed. Non-invasive Doppler ultrasound assessment of vascular function was performed. 22 The percentage of flow-mediated dilatation (FMD, %) of the brachial artery was measured by scans at rest and after reactive hyperaemia induced by forearm cuff release. The percentage of endothelium-independent nitrate-dependent vasodilation (NMD, %) was measured after a dose of 1.2 mg sublingual isosorbidedinitrate spray (Nitrosid ® ). Also, carotid and brachial IMT (mm) as well as carotid artery distensibility (Cdist, %/10 mmHg) were determined. The ultrasound methods used for the measurement of vascular parameters are described in detail in the literature. 23, 24 Clinical characteristics of the study subjects in the two groups of different genotype are shown in Table 1 .
Genotyping
Genotyping was performed from blood leukocyte DNA, which was extracted by using a DNA isolation kit (Puregene, Gentra systems, Minneapolis, MN, USA) according to the manufacturer's instructions. The genotype was determined as described earlier. 25 
Biochemical analysis
Hb, leukocyte count, erythrocyte sedimentation rate, cholesterol concentrations, triglycerides, HbA1 C , glucose, insulin, alat, crea and C-peptide concentration were determined with standardised methods at the Turku University Hospital (TYKSLAB), Finland.
Lymphocyte sub-class definitions
Blood samples were collected from 24 Leu7Pro-genotyped type 2 diabetic patients of the study group (10 heterozygous Leu7Pro7, 14 wild type Leu7Leu7 pair-matched controls). Lymphocytes were isolated with density gradient centrifugation using Ficoll-Paque Plus (GE Healthcare, Fairfield, CT, USA). Two parallel cell surface and intracellular staining assays were performed from each sample. The antigens used for determination of cell type and activation status are shown in Table 2 .
Surface staining. Isolated lymphocytes were suspended into ice-cold phosphate-buffered saline (PBS)-A (0.5 % bovine serum albumin, 0.1 % sodium azide in PBS) and divided into tubes containing the cell surface antibodies (1:20) for different lymphocyte sub-classes, as described in Table 2 . After 15 min incubation on ice in the dark, cells were washed twice with PBS and analysed immediately with flow cytometry.
Cell stimulation and intracellular staining. One aliquot of lymphocytes was stimulated with 10 ng/ml phorbol 12-myristrate 13-acetate (PMA) and 1 µM ionomycin in the presence of 1 µM monensin (Sigma-Aldrich, St. Louis, MO, USA) for 4 h at 37°C in 5% CO 2 , while another was used as unstimulated control. After stimulation, lymphocytes were first surface stained with phycoerythrin (PE)-antiCD4 antibody (1:10 in PBS-A) for 15 min on ice in the Table 2 . Isotype-matched controls IgG1-FITC, IgG1-PE and IgG2a-FITC (Serotec, Kidlington, Oxford, UK) were used to exclude non-specific binding of the antibodies. A volume of 100 µl of fresh whole blood was mixed with 1:10 antibody and incubated for 15 min in the dark at RT. Next, 2 ml of 1:10 diluted BD FACS™ Lysing Solution was added followed by 10 min incubation in the dark in RT. Cells were pelleted, washed with 2 ml 0.1% sodium azide in PBS, resuspended in 1% formaldehyde and analysed with flow cytometry.
Flow cytometry
Data were acquired using BD FACSCalibur™ and CellQuest™ software. Analysis gates were set for lymphocytes, granulocytes and monocytes according to their FSC-SSC profile. These gates were used for collecting the events stained with antibodies. In total 10,000 gated events were counted from each performed assay. Analysis was done using BD CellQuest™ software and the results were obtained as geometric mean percentages of gated events.
NPY assay
NPY was quantified from plasma using NPY Enzyme Immunoassay Kit (Phoenix Pharmaceuticals Inc., Burlingame, California, USA) according to the manufacturer's instructions.
Statistical methods
Comparisons of clinical characteristics between the genotypes were obtained using the t-test for normally distributed variables and the Mann-Whitney U test for skewed variables. Linear regression analysis was used for correlations between NPY concentrations and intracellular cytokines as well as intracellular cytokines and endothelial function.
Comparisons of leukocyte and vascular parameters as well as NPY concentrations were obtained using analysis of variance (ANOVA). IMT was adjusted to sex, age, BMI, systolic blood pressure (SBP) and LDL cholesterol, in analyses, and in addition to these parameters, insulin level was used as additional adjustment for Cdist. FMD and NMD were adjusted to gender, age, BMI, SBP, HDL cholesterol and brachial artery diameter. Leukocyte parameters and NPY concentrations were adjusted for sex, age and BMI. Logarithmic transformation was performed for skewed variables before regression analysis.
Results
The comparisons of measured inflammatory and vascular parameters between the two study groups Leu7Leu7 and Leu7Pro7 are summarised in Table 3 and the results of the regression analyses are detailed in Table 4 . The amount of platelet-granulocyte complexes was positively correlated with NPY concentration (p=0.008) and IMT (p=0.020) in the Leu7Pro7 group. IFN-γ expression correlated negatively with FMD also in the Leu7Pro7 group (p=0.037). However, Leu7Pro7 patients had fewer intracellular IFN-γ-positive T cells (Th1) than the Leu7Leu7 patients (p=0.033) ( Table 3 ). The expression of TF on monocytes correlated negatively with brachial artery diameter in Leu7Pro7 patients (p=0.019). The amount of B cells was positively correlated with NMD in the Leu7Pro7 group (p=0.039).
Activation marker CD11b expression on monocytes was positively correlated with Cdist in the Leu7Leu7 patients (p=0.026). NMD was also positively correlated with Cdist in the Leu7Leu7 group (p=0.008). IL-4 expression correlated negatively with Cdist in the Leu7Leu7 patients (p=0.032).
Monocyte TF positivity correlated positively with NMD when both genotypes were included (p=0.032). The amount of B cells was also positively correlated with NPY concentration when both genotypes were included (p=0.044).
Discussion
In this study we found that in diabetic patients of the Leu7Pro7 genotype, leukocyte activation, measured by the formation of platelet-granulocyte complexes, correlated positively with the amount of circulating NPY. This correlation was not found in the wild type Leu7Leu7 group. Increased amounts of platelet-leukocyte complexes have been associated with myocardial infarction. 26 NPY regulates the adhesion of leukocytes, 19 which may be the mechanism behind this significant association. NPY concentration per se did not vary significantly between the genotypes in the measured time point. However, NPY concentrations have been shown to vary between the genotypes depending on age, disease state and stress. 16, 27, 28 In the current study we found that the formation of platelet-granulocyte complexes correlated positively with increased IMT in the Leu7Pro7 group. This suggests that the formation of platelet-leukocyte complexes due to leukocyte activation could predict atherosclerosis in this genotype, since IMT increase is a sign of early atherosclerosis. Accelerated IMT increase has previously been associated with the Leu7Pro7 genotype in middle-aged men, 14 in elderly patients with type 2 diabetes and in healthy controls. 29 Our current results indicated that the intracellular amount of Th1 cell-type cytokine IFN-γ was negatively associated with FMD in the Leu7Pro7 group of patients, although the Pro7 allele carriers had a lower level of IFN-γ in the cells. This finding suggests that the Th1-type inflammatory response may be detrimental to the endothelial function in subjects with the Pro7 substitution. Previously, healthy subjects with the Pro7 substitution have been shown to have increased FMD compared with Leu7Leu7 subjects in studies of middle-aged men and prepubertal children, 30 but this has not been shown in diabetes patients. The harmful effect of IFN-γ on endothelium in subjects of the Leu7Pro7 genotype maybe related to NPY-mediated mechanisms in endothelial vasodilatation, since long-term treatment with NPY of endothelial cells of this genotype has been shown to reduce endothelial nitric oxide synthase (eNOS) mRNA and overall eNOS protein levels, 31 which are key elements mediating the FMD response. The lower level of intracellular IFN-γ observed in this study may be related to the effects of NPY on Th1 cell production of this cytokine. 18 TF is expressed in peripheral monocytes and atherosclerotic plaques, and plays a significant role in atherosclerosis progression and thrombus formation. 32 In the current study, brachial artery diameter was negatively associated with the expression of TF on monocytes in the Leu7Pro7 patients. The subjects without the Pro7 allele did not have this association. This is another important finding showing that a vessel parameter indicating atherosclerosis 33 is regulated by leukocyte activation in the diabetic patients of the Leu7Pro7 genotype.
Monocyte TF positivity correlated positively with NMD when both genotypes were included. NMD is a vascular response not dependent on the endothelium. Earlier studies on atherosclerosis and vascular function have indicated contradicting results when FMD and NMD have been studied in the same subjects, 34, 35 and suggest that different vascular responses may have unique relationships with inflammatory cell activation also. In addition, we found that the amount of B cells was positively correlated with NMD only in the Leu7Pro7 group of patients. Studies in mice have indicated a protective role of B cells in atherosclerosis, 36, 37 although the role of B cells in atherosclerosis has not been greatly investigated and remains to be clarified. On the other hand, the amount of B cells was positively correlated with NPY concentration in the whole study group of type 2 diabetes patients. The connection between B cells and NPY has not been comprehensively investigated. In rats, it has been shown that low-dose intravenous NPY decreases B-cell count and high-dose NPY increases it. 38 Since diabetes patients have an elevated concentration of NPY in their blood, according to our results, this relationship also seems valid in humans. CD11b expression on monocytes was positively correlated with Cdist in the Leu7Leu7 patients, which was not observed in the Leu7Pro7 patients. Furthermore, there was a positive association between Cdist and NMD in the Leu7Leu7 patients, which was not present in the carriers of the Pro7 allele in this study. This activation marker has been observed to be expressed at a higher level in patients with type 2 diabetes 8, 39 and in patients with ischemic heart disease. 40 In mice, CD11b expression has been reported as not essential for the development of atherosclerosis. 41 In our study, the higher expression of CD11b did not have a negative impact on Cdist, which supports the latter observation. Vice versa, in subjects with the wild type Leu7Leu7 genotype, this marker had a positive effect on some vascular function parameters.
In conclusion, our study has indicated that several associations of inflammatory and vascular parameters are related to the NPY gene Leu7Pro polymorphism, which has previously been shown to be linked to enhanced atherosclerosis. Most significantly, leukocyte activation, as measured by platelet-granulocyte complexes in blood, is positively associated with NPY concentrations and the level of atherosclerosis (IMT) in subjects of the Leu7Pro7 genotype. Also, we show in this study that monocyte IFN-γ and TF expression have negative associations with vascular function (FMD) or brachial artery diameter in these subjects. The other detailed association described in this study may provide new insight for the future studies on the development of atherosclerosis in prone subjects.
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